Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) Peptide
SPG20
宿主: 合成
BP, Imm
-
- 抗原 See all SPG20 products
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Immunogen (Imm)
- 序列
- EASGTDVKQL DQGNK
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- 缓冲液
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- 储存条件
- -20 °C
- 储存方法
- Shipped at ambient temperature, store at -20°C.
-
- 抗原
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
- 别名
- SPARTIN Peptide, TAHCCP1 Peptide, AI840044 Peptide, C79168 Peptide, mKIAA0610 Peptide, spartin Peptide, Spg20 Peptide, spg20a Peptide, zgc:172059 Peptide, spg20b Peptide, zgc:153766 Peptide, spartin Peptide, spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) Peptide, spartin a Peptide, spartin b Peptide, SPART Peptide, Spg20 Peptide, Spart Peptide, sparta Peptide, spartb Peptide
-
You are here:
